Close

Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs

Go back to Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 0.89 +0.02 (2.30%)
Previous Close $0.87    52 Week High $3.65 
Open $0.87    52 Week Low $1.24 
Day High $0.89    P/E N/A 
Day Low $0.87    EPS $0.00 
Volume 257,183